Articles tagged with Covid 19 Vaccines
A study of 1,678 participants found that low benefit expectations, negative experiences, and catastrophizing are associated with COVID-19 vaccination adverse effects. Clinician-patient interactions and public vaccine campaigns may be optimized by contextualizing information about vaccines.
Researchers examine how chronological and biological age impact vaccine effectiveness, finding that both factors influence immune system capacity to mount responses. The study highlights the need for further research into 'immune aging' risk and departures from healthy aging.
A study found that socially vulnerable populations have poorer COVID-19 outcomes despite similar vaccine effectiveness, due to lower vaccination rates. The VISION Network analyzed electronic health record data and immunization records to highlight the need for targeted public health efforts on vaccine coverage.
The study found that vaccination significantly reduces the risk of long COVID, while factors such as being overweight, female, smoker, or over 40 increase the likelihood of developing the condition. Vaccination halves people's risk of developing long Covid
A systematic review and meta-analysis found demographic characteristics, comorbidities, and severe COVID-19 increase the risk of long COVID. Vaccination is protective against developing long COVID sequelae.
Researchers at the University of Maryland School of Medicine are using mRNA vaccine technology to combat various infectious diseases. A new clinical trial aims to test an mRNA-based vaccine against malaria, with hopes for a rapid adaptive response to virus evolution and the manufacture of combination vaccines.
A recent study published in iScience has found that Covid-19 vaccination does not cause concerning changes to periods. Women who have been infected with the Covid-19 virus are at increased risk of menstrual changes such as missed or heavier periods.
Researchers have identified a highly conserved region of the SARS-CoV-2 spike protein that could be targeted to boost human antibody responses against any coronavirus. The discovery could aid the development of more powerful antibody drugs and vaccines against COVID-19 and emerging coronaviruses.
A study published in Nature Immunology found that antibodies from previously infected patients can neutralize variants of the COVID-19 disease, including the Omicron variant. These broadly neutralizing antibodies have unique biochemical and structural features that enable them to block the virus from entering human cells.
A new study has found that SARS-CoV-2 infection damages the CD8+ T cell response, which is crucial for fighting the virus. Vaccination after infection can still provide protection, but booster shots may be needed to boost immune-cell responses.
A new study by Boston University School of Public Health reveals a 104% increase in pregnancy-related deaths among American Indian/Alaska Native people, with rates nearly doubling from pre-pandemic levels. The Delta and Omicron variants contributed to the worsening burden of mortality, particularly among racial and ethnic minorities.
A Kaiser Permanente study found that receiving Paxlovid within 5 days of COVID-19 symptoms significantly reduced the risk of hospital admission or death. The medication was effective in people with prior immunity and all ages.
A multi-state study found COVID-19 mRNA vaccines remain protective during Omicron BA.4/BA.5 predominance, with estimated vaccine effectiveness of 68% against hospitalization within 7-119 days post-vaccination.
The study found that COVID-19 mRNA vaccine effectiveness decreased with time since the last dose, while booster doses increased protection. The findings suggest that vaccination strategies should prioritize boosters to maintain protection against severe illness.
A new study describes an optimized method for isolating and identifying nanobodies targeting SARS-CoV-2, which could lead to the development of effective therapies. The approach uses a yeast display method, reducing costs and time required for screening nanobody libraries.
A new meta-analysis found that sleeping fewer than six hours per night after COVID-19 vaccination was associated with a weakened antibody response. The study highlights the need for simple behavioral interventions like sufficient sleep to improve vaccine efficacy during the pandemic.
A small number of patients with acute myocarditis after COVID-19 vaccination showed signs of heart muscle inflammation, while asymptomatic patients had normal cardiac tissue. The study suggests that symptoms alone are a poor indicator of myocardial injury after vaccination.
Axillary lymphadenopathy after a COVID-19 vaccine booster dose resolves at a mean of 102 days. Findings support follow-up intervals of at least 12 weeks to avoid delaying screening mammography for suspected vaccine-related lymphadenopathy.
A University of Gothenburg study reveals that dementia is the dominant risk factor for COVID-19 infection and mortality among residents of Swedish nursing homes. Early-onset dementia was found to be the strongest association with increased mortality rates, particularly in the 65–75 age group.
A study found that a commercial water purifier may have caused Mycobacterium abscessus infections in 4 cardiac surgery patients due to chlorine depletion. The hospital's water system was contaminated via municipal water, emphasizing the importance of monitoring and preventing mycobacteria.
Researchers found that trust in federal, state, and local public health agencies was driven by beliefs in scientific expertise and provision of direct care, not control of outbreaks. Lower trust was related to concerns about conflicting recommendations and perceived political influence.
A recent study found that anxiety about contracting COVID-19 is a significant predictor of vaccine hesitancy. However, proactive coping, a trait involving future planning, also plays a surprising role in vaccine hesitation, amplifying it at both ends of the spectrum.
A 21-person commission of public health experts calls for networked communities sharing accurate vaccine information to counter misinformation. The US has seen a surge in anti-vaccine activism, leading to vaccine hesitancy and increased illnesses.
A new study shows that patients with liver cirrhosis have a lower immune response to COVID-19 vaccines, but this does not affect the vaccines' effectiveness. Age, type of vaccine, and viral hepatitis etiology also play a role in immune responses.
The US government invested at least $337 million in critical research leading to mRNA COVID-19 vaccines before the pandemic, and $31.6 billion during it. These public investments saved millions of lives and have potential to address future pandemics and treat other diseases.
A recent study found that public investment in critical research contributed significantly to the development of mRNA COVID-19 vaccines. The US government invested at least $337 million in research over 35 years, including basic science and vaccine development.
Researchers identify 32 human monoclonal antibodies that can block SARS-CoV-2, SARS-CoV-1, and MERS-CoV coronaviruses. These antibodies target a vulnerable site on the viral spike protein, offering potential for broad protection against future pandemics.
A study published in npj Vaccines found that clear communication strategies, such as emphasizing self-interest and common ground, can increase vaccination solidarity among citizens. The researchers recommend a crisis communication approach that highlights the risks of vaccine nationalism and promotes long-term profit orientation.
A study of 1.65 million BNT162b2 vaccinations among Ontario adolescents found a rare but significant risk of myocarditis or pericarditis. The researchers emphasize that while the events are uncommon, they should be weighed against the benefits of COVID-19 vaccination.
Researchers at Arizona State University describe an innovative therapy using transient expression in tobacco plants to produce a monoclonal antibody against SARS-CoV-2. This class 4 mAb provides key advantages over existing treatments, including mutation resistance and universal protection against emerging variants.
Researchers have found that the naturally occurring amino acid ALA can reduce the expression of ACE2 on cell membranes, potentially lowering SARS-CoV-2's infectious capabilities. The study also reveals an underlying mechanism involving the production of heme, which is boosted by co-administering ALA with an iron source.
An analysis of 13 million tweets suggests that celebrity tweets, particularly from politicians and news anchors, played a significant role in shaping public opinion on the COVID-19 pandemic in the US. The findings highlight the importance of monitoring social media activity to combat misinformation and promote health-protective behaviors.
A new Australian study found fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system, with some people receiving more effective protection than others. The study revealed a potential explanation for the connection between the AstraZeneca vaccine and blood clotting cases.
A new study published in Vaccines found that individuals with a university degree were more likely to believe in the effectiveness of COVID-19 preventive measures. The research also revealed that people with higher education levels had lower levels of trust in scientific misinformation, highlighting the importance of education in shapi...
A US study found that COVID-19 vaccination is associated with a lower risk of cardiovascular events, particularly among those with comorbidities. Even partial vaccination was linked to a reduced risk of adverse cardiovascular events. The research suggests that vaccination may have beneficial effects on post-COVID-19 complications.
A study found that vaccinated people are less likely to have opportunistic pathogens in their nose and throat, and also experience milder symptoms of COVID-19. This is attributed to the presence of transcriptionally active nasopharyngeal commensals, which play a key role in defining mild symptoms.
Researchers found that interactive simulation formats were more effective than conventional text-based formats in convincing vaccine-hesitant adults to get vaccinated. The study suggests that interactive simulations can boost people's decision-making competence, leading to positive changes in vaccination intentions and benefit-to-harm ...
A comprehensive review and meta-analysis published in The Lancet suggests that natural immunity from COVID-19 infection provides significant protection against hospitalization, symptomatic disease, and severe illness for at least 10 months. However, this protection declines over time, with an estimated 85% protection rate at one month ...
A new Northwestern University study suggests that COVID-19 boosters may be less effective due to pre-existing antibodies from initial vaccinations. The study found that these antibodies can rapidly clear the booster from the body, limiting its efficacy. Increasing time between vaccinations is also beneficial for the immune response.
A recent study published in JAMA Network Open found that COVID-19 vaccination significantly reduces the risk of developing new-onset diabetes following an infection. The research suggests a notable benefit of vaccination in protecting against this complication.
Researchers found a significant increase in new-onset diabetes after COVID-19 infection, with vaccination prior to infection showing protective effects. The study suggests that COVID-19 infection could be acting as a disease accelerator, amplifying risk for diabetes diagnosis.
Researchers estimated that three doses of Comirnaty and CoronaVac vaccines were 48% and 30% effective, respectively, in preventing Omicron infection. Boosters improved efficacy to 69% and 56%, but protection waned over time.
Researchers developed a new method to quantify the structure and quality of messenger RNA (mRNA) medicines using liquid chromatography, mass spectrometry, and software analysis. The platform can analyze all three key components of mRNA medicines simultaneously, providing unparalleled efficiency in checking for quality.
Researchers from the University of Colorado found that Paxlovid significantly reduced rates of hospitalization and death among non-hospitalized patients infected with recent Omicron subvariants. The study used real-world data from 28,000 patients and suggested a benefit for Paxlovid in preventing severe disease.
A recent study monitored the Italian province of Pescara for 18 months and found no increased risk of serious diseases among vaccinated individuals. The study revealed that vaccinated persons were more protected against COVID-19 and had lower rates of deaths and disease occurrences compared to non-vaccinated individuals.
A recent study published by The BMJ found that COVID-19 vaccination during pregnancy may have benefits for both mother and baby. Two doses of mRNA Covid-19 vaccine were highly effective against delta infection, while two doses against omicron infection showed moderate effectiveness. A third dose during pregnancy also bolstered protecti...
A study by Brown University researchers found that night shift nursing home staff had significantly lower rates of COVID-19 testing and primary vaccination compared to day shift staff. The study highlights the importance of considering work shifts in designing workplace health interventions.
A recent study found that individuals with conservative political leanings tend to favor hydroxychloroquine and view vaccination unfavorably. Physicians also exhibit similar biases, with conservative physicians being more likely to prescribe hydroxychloroquine. The study suggests that education alone may not be enough to combat polariz...
A Rutgers study found that people who know someone who became ill with COVID-19 or died from the disease are twice as likely to receive a COVID-19 vaccine. The study also found that essential workers and those with better health status were more likely to get vaccinated.
Researchers develop eRapid sensor technology to detect SARS-CoV-2 antibodies, enabling fast and multiplexed testing at the point-of-care. The device distinguishes between antibody types targeting different viral proteins with high sensitivity and specificity.
Suboptimal COVID-19 vaccination coverage was found in a study of 5.6 million US veterans, with younger and rural veterans showing lower rates of primary vaccination and booster shots needed for all veterans
A large Dutch study found that the BCG vaccine does not protect elderly people with co-morbidities against COVID-19 symptoms. The study analyzed 6,112 participants and showed no difference in disease manifestations or hospitalizations between those who received the vaccine and those who received a placebo.
Researchers developed a new way to increase vaccine potency by changing the structural location of antigens and adjuvants. This approach, called 'rational vaccinology,' allows for precise dosing and tailored presentation of vaccine components, leading to improved immune response and cancer cell targeting.
A Hong Kong study published in Canadian Medical Association Journal found a 90% reduction in COVID-19 deaths among adults with multimorbidity who received a booster dose of vaccine. The study, which included over 120,000 participants, suggests that booster vaccination can significantly lower mortality rates in vulnerable populations.
A study by researchers in Brazil found that loss of muscle mass during COVID-19 hospitalization is associated with the development of persistent symptoms such as weakness, shortness of breath, and fatigue. The study also showed that patients who lost more muscle mass had higher healthcare costs six months after discharge.
A study by OHSU researchers found that immunity from COVID-19 gathers strength over time, indicating that vaccination should not be delayed. The study suggests that vaccine boosters can be spaced no more frequently than a year apart among healthy individuals.
A peer-reviewed study published in The New England Journal of Medicine found that updated bivalent mRNA vaccines are more effective than original monovalent boosters at preventing COVID-19 hospitalization and death. Booster effectiveness peaked at four weeks after receipt and waned afterward, with average effectiveness against severe i...
A new COVID-19 vaccine has been tested in humans, showing a good immune response and few side effects. The effectiveness of the vaccine is currently being investigated, but initial results suggest it could provide long-lasting immunity.
The COVID-19 Prevention Network's coordinated approach to Phase 3 clinical trials has yielded a comprehensive database of trial participants' data. This dataset will help researchers address pressing questions about SARS-CoV-2 and inform future vaccine development.
A systematic review and meta-analysis of 17 studies found mRNA COVID-19 vaccination to be associated with lower risks of SARS-CoV-2 infections, severe illnesses, and hospitalizations. While vaccination was linked to higher adverse event rates, the frequency of severe adverse events remained low.